Literature DB >> 34010593

"D" matters in recombinant AAV DNA packaging.

Junping Zhang1, Ping Guo2, Yinxia Xu2, Patrick L Mulcrone1, R Jude Samulski3, Weidong Xiao4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34010593      PMCID： PMC8178517          DOI： 10.1016/j.ymthe.2021.05.002

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   12.910


× No keyword cloud information.
  15 in total

1.  Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.

Authors:  Gilliane Chadeuf; Carine Ciron; Philippe Moullier; Anna Salvetti
Journal:  Mol Ther       Date:  2005-10       Impact factor: 11.454

2.  Factors influencing recombinant adeno-associated virus production.

Authors:  A Salvetti; S Orève; G Chadeuf; D Favre; Y Cherel; P Champion-Arnaud; J David-Ameline; P Moullier
Journal:  Hum Gene Ther       Date:  1998-03-20       Impact factor: 5.695

3.  Role for highly regulated rep gene expression in adeno-associated virus vector production.

Authors:  J Li; R J Samulski; X Xiao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.

Authors:  Joshua C Grieger; Stephen M Soltys; Richard Jude Samulski
Journal:  Mol Ther       Date:  2015-10-06       Impact factor: 11.454

5.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Codon Modification and PAMPs in Clinical AAV Vectors: The Tortoise or the Hare?

Authors:  J Fraser Wright
Journal:  Mol Ther       Date:  2020-02-08       Impact factor: 11.454

7.  Gene therapy vectors based on adeno-associated virus type 1.

Authors:  W Xiao; N Chirmule; S C Berta; B McCullough; G Gao; J M Wilson
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  In vitro resolution of covalently joined AAV chromosome ends.

Authors:  R O Snyder; R J Samulski; N Muzyczka
Journal:  Cell       Date:  1990-01-12       Impact factor: 41.582

9.  Rescue and replication signals of the adeno-associated virus 2 genome.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Mol Biol       Date:  1995-07-28       Impact factor: 5.469

Review 10.  Product-Related Impurities in Clinical-Grade Recombinant AAV Vectors: Characterization and Risk Assessment.

Authors:  J Fraser Wright
Journal:  Biomedicines       Date:  2014-03-03
View more
  1 in total

1.  Reply to "D" matters in recombinant AAV packaging.

Authors:  Jakob Shoti; Keyun Qing; Arun Srivastava
Journal:  Mol Ther       Date:  2021-08-25       Impact factor: 12.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.